Abstract
The threat of antibiotic resistance is growing at an alarming pace, perhaps more rapidly in developing countries. Aside from the abuse of antibiotics, a number of circumstances converge to this rapid growth and spread, ranging from the biological traits that bacteria deploy to face antibiotics, which we are still trying to understand, to regulatory and financial issues behind antibiotic abuse. And, aside from the more-difficult-to-cure side of resistance, which is bad enough, bacteria are evolving to be more competent to face environmental stress, which includes antibiotics, present and future ones. In developing countries, we face peculiarities that go from antibiotic self-prescription to poor sanitary conditions, even at hospitals, that foster the threat of particular multi-resistant pathogens that are not common in developed countries and against which no new antibiotics are being investigated. In addition to the local repercussions of these peculiarities upon resistance trends, it is important to realize that these can easily cross borders in this era of globalization. A worldwide strategy must be developed and enforced if we are to have a good start at the post-antibiotic era.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aiello, A.E. and Larson, E.L. (2003) “Antibacterial cleaning and hygiene products as emerging risk factor for antibiotic resistance in the community.” Lancet Infectious Diseases 3, 501–506.
Amábile-Cuevas, C.F. (1993) Origin, evolution and spread of antibiotic resistance genes. RG Landes, Austin.
Amábile-Cuevas, C.F. (2003) “Gathering of resistance genes in gram-negative bacteria: an overview”. In: C.F. Amábile-Cuevas (Ed.), Multiple drug resistant bacteria. Horizon Scientific Press, Wymondham, UK, pp. 9–31.
Amábile-Cuevas, C.F., Cabrera, R., Fuchs, L.Y. and Valenzuela, F. (1998) “Antibiotic resistance and prescription practices in developing countries.” Methods in Microbiology 27, 587–594.
Amábile-Cuevas, C.F. and Chicurel, M.E. (1992) “Bacterial plasmids and gene flux.” Cell 70, 189–199.
Balsalobre, L., Ferrándiz, M.J., Liñares, J., Tubau, F. and de la Campa, A.G. (2003) “Viridans group streptococci are donors in horizontal transfer of topoisomerase IV genes to Streptococcus pneumoniae.” Antimicrobial Agents and Chemotherapy 47, 2072–2081.
Beaber, J.W., Hochhut, B. and Waldor, M.K. (2003) “SOS response promotes horizontal dissemination of antibiotic resistance genes.” Nature 427, 72–74.
Becker, D., Selbach, M., Rollenhagen, C., Ballmaier, M., Meyer, T.F., Mann, M. and Bumann, D. (2006) “Robust Salmonella metabolism limits possibilities for new antimicrobials.” Nature 440, 303–307.
Brown, E.W., LeClerc, J.E., Li, B., Payne, W.L. and Cebula, T.S. (2001) “Phylogenetic evidence for horizontal transfer of mutS alleles among naturally occurring Escherichia coli strains.” Journal of Bacteriology 183, 1631–1644.
Buxton, I.L.O. (2006) “Principles of prescription order writing and patient compliance.” In: L.L. Brunton, J.S. Lazo and K.L. Parker (Ed.), The pharmacological basis of therapeutics. McGraw-Hill, New York, pp. 1777–1786.
Calva, J.J., Niebla-Pérez, A., Rodríguez-Lemoine, V., Santos, J.I. and Amábile-Cuevas, C.F. (1996) “Antibiotic usage and antibiotic resistance in Latin America.” In: C.F. Amábile-Cuevas (Ed.), Antibiotic resistance: from molecular basics to therapeutic options. R.G. Landes/Chapman & Hall, Austin/New York, pp. 73–97.
Casellas, J.M. and Quinteros, M.G. (2007) “A Latin American “point de vue” on the epidemiology, control, and treatment options of infections caused by extended-spectrum beta-lactamase producers.” In: C.F. Amábile-Cuevas (Ed.), Antimicrobial resistance in bacteria. Horizon Bioscience, Wymondham, pp. 99–122.
Courvalin, P. (1990) “Plasmid-mediated 4-quinolone resistance: a real or apparent absence?” Antimicrobial Agents and Chemotherapy 34, 681–684.
Davin-Regli, A. and Pagès, J.-M. (2007) “Regulation of efflux pumps in Enterobacteriaceae: genetic and chemical effectors.” In: C.F. Amábile-Cuevas (Ed.), Antimicrobial resistance in bacteria. Horizon Bioscience, Wymondham, UK, pp. 55–75.
Delissalde, F. and Amábile-Cuevas, C.F. (2004) “Comparison of antibiotic susceptibility and plasmid content, between biofilm producing and non-producing clinical isolates of Pseudomonas aeruginosa.” International Journal of Antimicrobial Agents 24, 405–408.
Demple, B. and Amábile-Cuevas, C.F. (2003) “Multiple resistance mediated by individual genetic loci.” In: C.F. Amábile-Cuevas (Ed.), Multiple drug resistant bacteria. Horizon Scientific Press, Wymondham, UK, pp. 61–80.
Díaz-Mejía, J.J., Amábile-Cuevas, C.F., Rosas, I. and Souza, V. (2008) “An analysis of the evolutionary relationships of integron integrases, with emphasis on the prevalence of class 1 integron in Escherichia coli isolates from clinical and environmental origins.” Microbiology 154, 94–102.
Fuchs, L.Y., Reyna, F., Chihu, L. and Carrillo, B. (1996) “Molecular aspects of fluoroquinolone resistance.” In: C.F. Amábile-Cuevas (Ed.), Antibiotic resistance: from molecular basics to therapeutic options. Landes/Chapman & Hall, Austin/New York, pp. 147–174.
Gilbert, P., McBain, A. and Lindsay, S. (2007) “Biofilms, multi-resistance, and persistence.” In: C.F. Amábile-Cuevas (Ed.), Antimicrobial resistance in bacteria. Horizon Bioscience, Wymondham, UK, pp. 77–98.
Heinemann, J.A. and Goven, J. (2007) “The social context of drug discovery and safety testing.” In: C.F. Amábile-Cuevas (Ed.), Antimicrobial resistance in bacteria. Horizon Bioscience, Wymondham, pp. 179–196.
Heinemann, J.A. and Silby, M.W. (2003) “Horizontal gene transfer and the selection of antibiotic resistance.” In: C.F. Amábile-Cuevas (Ed.), Multiple drug resistant bacteria. Horizon, Wymondham, pp. 161–178.
Hooper, D.C., Wolfson, J.S., Souza, K.S., Ng, E.Y., McHugh, G.L. and Swartz, M.N. (1989) “Mechanisms of quinolone resistance in Escherichia coli: characterization of nfxB and cfxB, two mutant resistance loci decreasing norfloxacin accumulation.” Antimicrobial Agents and Chemotherapy 33, 283–290.
Jiménez-Arribas, G., Léautaud, V. and Amábile-Cuevas, C.F. (2001) “Regulatory locus soxRS partially protects Escherichia coli against ozone.” FEMS Microbiology Letters 195, 175–177.
Miller, C., Thomsen, L.E., Gaggero, C., Mosseri, R., Ingmer, H. and Cohen, S.N. (2004) “SOS response induction by β-lactams and bacterial defense against antibiotic lethality.” Science 305, 1629–1631.
Outterson, K., Samora, J.B. and Keller-Cuda, K. (2007) “Will longer antimicrobial patents improve global public health?” Lancet Infectious Diseases 7, 559–566.
Robicsek, A., Strahilevitz, J., Jacoby, G.A., Macielag, M., Abbanat, D., Park, C.H., Bush, K. and Hooper, D.C. (2006) “Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase.” Nature Medicine 12, 83–88.
Tran, J.H. and Jacoby, G.A. (2002) “Mechanism of plasmid-mediated quinolone resistance.” Proceedings of the National Academy of Sciences USA 99, 5638–5642.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Amábile-Cuevas, C.F. (2010). Global Perspectives of Antibiotic Resistance. In: Sosa, A., Byarugaba, D., Amábile-Cuevas, C., Hsueh, PR., Kariuki, S., Okeke, I. (eds) Antimicrobial Resistance in Developing Countries. Springer, New York, NY. https://doi.org/10.1007/978-0-387-89370-9_1
Download citation
DOI: https://doi.org/10.1007/978-0-387-89370-9_1
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-89369-3
Online ISBN: 978-0-387-89370-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)